FDA Approved: KIMYRSA — Original Application (Melinta Therapeutics, LLC)

View source ↗

Summary

FDA approved KIMYRSA (oritavancin diphosphate) from Melinta Therapeutics, LLC for the treatment of acute bacterial skin and skin structure infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infections

Drugs mentioned

• KIMYRSA (oritavancin diphosphate)

Snippet

ORIG AP for KIMYRSA (ORITAVANCIN DIPHOSPHATE)